Investing.com - Intracellular Th reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Intracellular Th announced earnings per share of $-0.57 on revenue of $71.9M. Analysts polled by Investing.com anticipated EPS of $-0.81 on revenue of $65.88M.
Intracellular Th shares are down 26.01% from the beginning of the year and are trading at $50.81 , down-from-52-week-high.
Intracellular Th shares gained 10.88% in intra-day trade the report.
Intracellular Th follows other major Healthcare sector earnings this month
Intracellular Th's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar